Adjunctive antidepressants in bipolar depression: A cohort study of six- and twelve-months rehospitalization rates
European Neuropsychopharmacology Feb 17, 2018
Shvartzman Y, et al. - This trial was formulated in order to compare the rehospitalization rates of patients with bipolar disorder (BD)-I depressive episode who were discharged with mood stabilizers (MSs) and/or atypical antipsychotics (AAPs) with or without adjunctive antidepressants (ADs). Data unveiled a lower rate of and a longer time to rehospitalization due to adjunctive-AD therapy to MS/AAP at discharge from BD-I depressive episode hospitalization during a 1-year follow up period.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries